Vanda Pharmaceuticals Stock
Price
Target price
€3.74
€3.74
0.520%
0.02
0.520%
€17.37
15.08.25 / Tradegate
WKN: A0JJT3 / Symbol: VNDA / Name: Vanda Pharma / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Vanda Pharmaceuticals Stock
The Vanda Pharmaceuticals stock is trending slightly upwards today, with an increase of €0.020 (0.520%) compared to yesterday's price.
With 9 Buy predictions and only 1 Sell predictions the community sentiment for the stock is positive.
With a target price of 17 € there is potential for a 354.55% increase which would mean more than doubling the current price of 3.74 € for Vanda Pharmaceuticals.
So far the community has only identified positive things for Vanda Pharmaceuticals stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".
Pros and Cons of Vanda Pharmaceuticals in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
S********** s********
?
B****
Cons
?
M***** P*******
?
C******** o* t** e**********
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Vanda Pharmaceuticals vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Vanda Pharmaceuticals | 0.520% | 3.889% | -9.223% | -20.426% | -18.341% | -63.333% | -63.333% |
| Krystal Biotech | -0.930% | 7.757% | 0.824% | -27.257% | -15.572% | 59.627% | - |
| Ardelyx Inc. | 1.990% | 13.795% | 31.527% | -4.781% | 2.679% | 437.367% | 7.281% |
| Evolus Inc | -0.930% | 6.000% | -32.484% | -56.198% | -49.524% | -41.436% | 77.733% |
Comments
Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) was upgraded by analysts at Cantor Fitzgerald to a "strong-buy" rating.
Show more
Ratings data for VNDA provided by MarketBeat
Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $13.00 price target on the stock.
Show more
Ratings data for VNDA provided by MarketBeat
Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $20.00 price target on the stock.
Show more
Ratings data for VNDA provided by MarketBeat
